The sigma-1 receptor binds to the NaV1.5 protein in breast cancer to form a compound with quadruple symmetry, which shifts the NaV1.5 protein to the plasma membrane, thus increasing metastatic activity [54, 55]. Here, SCN5A is linked to breast cancer.